157 related articles for article (PubMed ID: 12883222)
1. A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant.
Ogunseinde BA; Wimmers E; Washington B; Iyob M; Cropper T; Callender CO
Transplantation; 2003 Jul; 76(2):448. PubMed ID: 12883222
[No Abstract] [Full Text] [Related]
2. Acquired Glanzmann's thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus.
Morath C; Hoffmann T; Kirchhoff EM; Sis J; Zeier M; Scharf RE; Andrassy K
Thromb Haemost; 2005 Oct; 94(4):879-80. PubMed ID: 16270646
[No Abstract] [Full Text] [Related]
3. Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis.
Felldin M; Bäckman L; Brattström C; Bentdal O; Nordal K; Claesson K; Persson NH
Transplant Proc; 1995 Dec; 27(6):3425. PubMed ID: 8540032
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
5. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma occurring in a cardiac transplant patient on tacrolimus.
Chua R; Macdonald P
Heart Lung Circ; 2006 Oct; 15(5):340-1. PubMed ID: 16781193
[TBL] [Abstract][Full Text] [Related]
7. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus based immunosuppression.
First MR
J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
[TBL] [Abstract][Full Text] [Related]
9. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.
Steg RE; Kessinger A; Wszolek ZK
Bone Marrow Transplant; 1999 May; 23(9):959-62. PubMed ID: 10338054
[TBL] [Abstract][Full Text] [Related]
10. Fever of unknown origin in renal transplant patients with tacrolimus.
Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
[TBL] [Abstract][Full Text] [Related]
12. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
[TBL] [Abstract][Full Text] [Related]
13. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682
[TBL] [Abstract][Full Text] [Related]
14. Diabetic ketoacidosis associated with acute pancreatitis in a heart transplant recipient treated with tacrolimus.
Im MS; Ahn HS; Cho HJ; Kim KB; Lee HY
Exp Clin Transplant; 2013 Feb; 11(1):72-4. PubMed ID: 23075084
[TBL] [Abstract][Full Text] [Related]
15. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
16. Normocalcaemic normomagnesaemic tetany with tacrolimus.
Aiyangar A; Chowdhary P; Rao K; Kiran K
Nephrology (Carlton); 2011 Nov; 16(8):784-5. PubMed ID: 22029645
[No Abstract] [Full Text] [Related]
17. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
[TBL] [Abstract][Full Text] [Related]
18. Serious interaction between tacrolimus FK506 and chloramphenicol in a kidney-pancreas transplant recipient.
Bakri R; Breen C; Maclean D; Taylor J; Goldsmith D
Transpl Int; 2003 Jun; 16(6):441-3. PubMed ID: 12819878
[No Abstract] [Full Text] [Related]
19. [Acute peripheral demyelinating polyneuropathy and acute renal failure after administration of FK506].
Laham G; Vilches A; Jost L; Jost L; Nogués M
Medicina (B Aires); 2001; 61(4):445-6. PubMed ID: 11563175
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus may be associated with lower osteonecrosis rates after renal transplantation.
Sakai T; Sugano N; Kokado Y; Takahara S; Ohzono K; Yoshikawa H
Clin Orthop Relat Res; 2003 Oct; (415):163-70. PubMed ID: 14612643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
